Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Furqan M. Abdulelah"'
Autor:
Dhiaa lattef Gossa Al-Saadde, Ali Murtaza Haider, Arsalan Ali, Ebraheem Abdu Musad Saleh, Abduladheem Turki Jalil, Furqan M. Abdulelah, Rosario Mireya Romero-Parra, Nahla A. Tayyib, Andrés Alexis Ramírez-Coronel, Ameer S. Alkhayyat
Publikováno v:
Heliyon, Vol 9, Iss 9, Pp e19826- (2023)
In the recent years, micronutrients play an important role in improving body health with preventing and treating of chronic diseases. Chromium is one of the vital minerals involved in the regulation of insulin action. According to abundant evidences
Externí odkaz:
https://doaj.org/article/3a3c1a3b2d294ac38b53f428bc3563b7
Publikováno v:
Al-Mustansiriyah Journal of Pharmaceutical Sciences, Vol 22, Iss 4 (2023)
Mucopolysaccharidosis I (MPS I) or Hurler and Mucopolysaccharidosis VI (MPS VI) or Maroteaux-Lamy syndrome are infrequent genetic disorder inherited as an autosomal recessive disease attributed to genetic variants genetic variant causing α-L idu
Externí odkaz:
https://doaj.org/article/26d428542f4449a6b47f6ccf18c10f62
Autor:
Marwa Hazem Jasim, Iman Sabah Jaafar, Methaq Hamad Sabar, Masar Basim Mohsin Mohamed, Doaa Abbas Zghair, Furqan M. Abdulelah
Publikováno v:
International Journal of Research in Pharmaceutical Sciences. 11:2638-2649
Sodium alginate, calcium carbonate, and guar gum were mixed with oils such as olive oil (OO), sesame oil (SO), and medium chain triglyceride (MCT). The oily formulations were found to simplify the preparation of in situ floating gel. This was the aim
Publikováno v:
International Journal of Drug Delivery Technology. 10:136-140
Metastatic breast cancer patients may acquire oral morbidity from therapeutic procedures. A common adverse event (AE) of the Mammalian target of rapamycin (mTOR) inhibitor is associated stomatitis (mIAS) secondary to mTOR inhibitor therapy, which hav
Publikováno v:
F1000Research. 12:395
Background: Mucopolysaccharidosis (MPS) is a rare hereditary inborn error of metabolism that represents the largest heterogeneous group of lysosomal storage diseases (LSD) and is characterized by multiorgan impairment due to glycosaminoglycans (GAGs)
The present study involves the utilization of metal oxide nanoparticles, zinc oxide (ZnO), as a drug delivery module for the antihypertensive drug, azilsartan, as a tool of particle size reduction. According to biopharmaceutical classification system
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c811638db121269540a2f4c07ad8e8e5
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::118ef071dc8a84b67ff8ad00c8b54be4
http://www.scopus.com/inward/record.url?eid=2-s2.0-85073870255&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-85073870255&partnerID=MN8TOARS
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2b93bdc00b3813861767f2c69f41fe42
http://www.scopus.com/inward/record.url?eid=2-s2.0-85077436052&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-85077436052&partnerID=MN8TOARS